Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients

Overview of attention for article published in Genome Medicine, October 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

twitter: 11 X users

patent: 2 patents

Citations

dimensions_citation: 148 Dimensions

Readers on

mendeley: 134 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 148 publications that cite this research output.

148

The most recent citing publications are shown below. View all 148 publications that cite this research output on Dimensions.

Gut microbiome is associated with recurrence-free survival in patients with resected Stage IIIB-D or Stage IV melanoma treated with immune checkpoint inhibitors

Preprint in bioRxiv (April 2024)

Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific Diseases

Article in International Journal of Molecular Sciences (April 2024)

Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy

Article in Cell Reports Medicine (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.